AMENDMENT NO. 1 TO SUBLEASE AGREEMENT RESEARCH PARK BUILDING - PHASE VSublease Agreement • August 12th, 2010 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances
Contract Type FiledAugust 12th, 2010 Company IndustryTHIS AMENDMENT NO. 1 TO SUBLEASE AGREEMENT (the “First Amendment”) is made and entered into effective as of November 11, 2009 by and between Myriad Genetics, Inc. (the “Landlord”), and Myriad Pharmaceuticals, Inc. (the “Tenant”).
AMENDMENT NO. 2 TO SUBLEASE AGREEMENT RESEARCH PARK BUILDING - PHASE VSublease Agreement • August 12th, 2010 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances
Contract Type FiledAugust 12th, 2010 Company IndustryTHIS AMENDMENT NO. 2 TO SUBLEASE AGREEMENT (the “Second Amendment”) is made and entered into on February 19, 2010 by and between Myriad Genetics, Inc. (the “Landlord”) and Myriad Pharmaceuticals, Inc. (the “Tenant”).